Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.34% |
| 2 | Technology | 12.68% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Financials | 10.32% |
| 5 | Consumer Staples | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Hain Celestial
HAIN
$52.4M
| $3.08M | ﹤0.01% |
143,222
+131,100
| +1,082% | +$2.75M |
|
|
PRCP
2052
DELISTED
Perceptron Inc
PRCP
| $3.06M | ﹤0.01% |
637,935
+24,805
| +4% | +$112K |
|
2053
Vermilion Energy
VET
$1.73B
| $3.04M | ﹤0.01% |
182,042
+82,442
| +83% | +$1.43M |
|
2054
LKQ Corp
LKQ
$6.43B
| $3.03M | ﹤0.01% |
96,386
-74,974
| -44% | -$2.05M |
|
|
RJET
2055
Republic Airways Holdings
RJET
$952M
| $3.03M | ﹤0.01% |
29,947
+1,394
| +5% | +$169K |
|
2056
Townsquare Media
TSQ
$104M
| $3.03M | ﹤0.01% |
430,745
+5,708
| +1% | +$34.5K |
|
2057
Akamai
AKAM
$18B
| $3.02M | ﹤0.01% |
33,100
-685,500
| -95% | -$59.5M |
|
2058
Alpha Metallurgical Resources
AMR
$2.11B
| $3.02M | ﹤0.01% |
108,100
+59,200
| +121% | +$2.06M |
|
2059
Great Elm Group
GEG
$67.7M
| $3.02M | ﹤0.01% |
821,704
+12,949
| +2% | +$50.2K |
|
2060
Ryder
R
$10.1B
| $3.01M | ﹤0.01% |
58,200
-2,200
| -4% | -$115K |
|
2061
Amcor
AMCR
$21.3B
| $2.99M | ﹤0.01% |
62,213
-136,719
| -69% | -$7.06M |
|
2062
Miller Industries
MLR
$645M
| $2.99M | ﹤0.01% |
89,700
-38,200
| -30% | -$1.22M |
|
|
GCP
2063
DELISTED
GCP Applied Technologies Inc.
GCP
| $2.98M | ﹤0.01% |
155,000
-166,400
| -52% | -$3.35M |
|
|
FMBI
2064
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $2.98M | ﹤0.01% |
152,771
-33,000
| -18% | -$657K |
|
|
SYRS
2065
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $2.98M | ﹤0.01% |
28,660
-1,080
| -4% | -$102K |
|
|
VRTV
2066
DELISTED
VERITIV CORPORATION
VRTV
| $2.94M | ﹤0.01% |
162,400
+69,000
| +74% | +$1.19M |
|
|
AIU
2067
DELISTED
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
| $2.93M | ﹤0.01% |
3,176
+543
| +21% | +$520K |
|
2068
Resources Connection
RGP
$145M
| $2.93M | ﹤0.01% |
172,542
+82,072
| +91% | +$1.38M |
|
|
YELL
2069
DELISTED
Yellow Corporation Common Stock
YELL
| $2.92M | ﹤0.01% |
966,253
+141,267
| +17% | +$444K |
|
2070
Clear Channel Outdoor Holdings
CCO
$1.19B
| $2.92M | ﹤0.01% |
1,157,049
-916,100
| -44% | -$2.87M |
|
2071
ICF International
ICFI
$1.59B
| $2.91M | ﹤0.01% |
34,500
-12,613
| -27% | -$1.02M |
|
2072
Alico
ALCO
$297M
| $2.91M | ﹤0.01% |
85,424
+14,717
| +21% | +$467K |
|
2073
argenx
ARGX
$53.3B
| $2.91M | ﹤0.01% |
25,500
-56,900
| -69% | -$7.69M |
|
|
KDNY
2074
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $2.9M | ﹤0.01% |
547,640
+185,200
| +51% | +$1.23M |
|
2075
ORIX
IX
$43.6B
| $2.9M | ﹤0.01% |
193,000
+86,160
| +81% | +$1.29M |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.